| Date | Time | Source | Headline | Symbol | Company |
| 12/01/2012 | 17:15 | Zacks | Allos Therapeutics Cut to Neutral - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 11/01/2012 | 13:15 | Zacks | AMAG Q4 Sales Set to Disappoint - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/01/2012 | 13:11 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 10/01/2012 | 13:00 | Business Wire | Allos Therapeutics Reports 2011 Financial Highlights and Key Business Priorities | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/12/2011 | 22:00 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 23/12/2011 | 21:51 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 21/12/2011 | 13:00 | Business Wire | Allos Therapeutics Invites Investors to Listen to Webcast of Presentation at J.P. Morgan Healthcare Conference | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 21:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 21:34 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 21:32 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 21:31 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 21:30 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 15/12/2011 | 15:00 | Zacks | AMAG's Feraheme Gets Canada Nod - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/12/2011 | 21:16 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 25/11/2011 | 12:15 | Zacks | Allos Continues to Outperform - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 18/11/2011 | 13:00 | Zacks | AMAG Hires Financial Advisor - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:08 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:07 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:06 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:05 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 17/11/2011 | 22:02 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/11/2011 | 13:30 | Zacks | Allos Narrows Loss - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 08/11/2011 | 09:15 | Zacks | Loss Shrinks at AMAG, CEO Departs - Analyst Blog | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 04/11/2011 | 09:05 | Zacks | Company News for November 4, 2011 - Corporate Summary | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/11/2011 | 11:07 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/11/2011 | 11:04 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 03/11/2011 | 11:00 | Business Wire | Allos Therapeutics Reports Third Quarter 2011 Financial Results | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |
| 26/10/2011 | 15:53 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ALTH | Allos Therapeutics, Inc. (MM) |